Findings reference
Find a precise term among 2,612 objective findings.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
specimen matrix | type of material tested, such as serum or whole blood | The original report identifies the specimen matrix as plasma. | Objective | Drug levels - analyte, specimen and reporting |
total concentration | bound and unbound drug measured together | The total concentration was measured on the same draw as free drug. | Objective | Drug levels - analyte, specimen and reporting |
unbound fraction | proportion of the total drug that is not protein bound | The report gives the unbound fraction as a percentage. | Objective | Drug levels - analyte, specimen and reporting |
unit of measure | scale used for a numerical result | The unit of measure on the original concentration is ng/mL. | Objective | Drug levels - analyte, specimen and reporting |
upper limit | highest applicable value on a stated scale or interval | The assay upper limit is given in the laboratory comment. | Objective | Drug levels - analyte, specimen and reporting |
whole-blood level | concentration measured in whole blood | The tacrolimus whole-blood level is listed with the assay method. | Objective | Drug levels - analyte, specimen and reporting |
actual interval | time between documented administrations | The actual interval between the two evening doses was 26 hours. | Objective | Drug levels - collection and dose timing |
administration time | when the patient actually received a dose | The recorded administration time was later than the scheduled time. | Objective | Drug levels - collection and dose timing |
baseline level | concentration measured before a defined change | The baseline level predates the formulation switch. | Objective | Drug levels - collection and dose timing |
collection time | when the specimen was actually obtained | The collection time was 07:42 according to the laboratory record. | Objective | Drug levels - collection and dose timing |
collection window | drug- and protocol-specific period intended for sampling | The draw occurred within the specified collection window. | Objective | Drug levels - collection and dose timing |
delayed dose | dose given later than planned | The delayed dose was administered at 11:15. | Objective | Drug levels - collection and dose timing |
dosing history | times and amounts actually received | The available dosing history covers the three administrations preceding the specimen. | Objective | Drug levels - collection and dose timing |
dosing interval | time between successive doses | The last observed dosing interval was longer than the prescribed interval. | Objective | Drug levels - collection and dose timing |
draw site | location or access used for collection | The documented draw site was a peripheral vein in the opposite arm. | Objective | Drug levels - collection and dose timing |
| time between two identified events | The elapsed time from infusion completion to collection was 40 minutes. | Objective | Drug levels - collection and dose timing | |
end of infusion | time when drug delivery actually finished | The end of infusion was recorded at 10:12 in the pump history. | Objective | Drug levels - collection and dose timing |
held dose | scheduled administration intentionally withheld | A held dose is documented on the evening before sampling. | Objective | Drug levels - collection and dose timing |
infusion duration | elapsed time from actual start to actual completion | The infusion duration was 90 minutes by the pump record. | Objective | Drug levels - collection and dose timing |
infusion start | time when drug delivery began | The pump log places the infusion start at 08:20. | Objective | Drug levels - collection and dose timing |
last confirmed dose | last administration with a verified time | The last confirmed dose was given before transfer from the outside facility. | Objective | Drug levels - collection and dose timing |
| most recent dose actually received before sampling | The last dose was given at 21:40 the evening before collection. | Objective | Drug levels - collection and dose timing | |
| specimen collected through a vascular access device | The sample was a line draw from the documented lumen. | Objective | Drug levels - collection and dose timing | |
next dose | dose following the sample | The next dose was administered 15 minutes after the blood draw. | Objective | Drug levels - collection and dose timing |
observed dose | administration witnessed by the team | The study sample followed an observed dose in clinic. | Objective | Drug levels - collection and dose timing |